Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

10.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.8K
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.6K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.6K
Hypoxia01:23

Hypoxia

2.2K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
2.2K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

425
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
425
Nursing Clinical Information System01:27

Nursing Clinical Information System

1.3K
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial Intelligence-Powered Radiotherapy for Resource-Limited Settings: Advancing Cervical and Prostate Cancer Treatment Planning With the Radiation Planning Assistant.

JCO global oncology·2026
Same author

Bayesian networks as prognostic models in oncology: a systematic review and recommendations for clinical practice.

BMJ oncology·2026
Same author

Corrigendum to "Long-term outcomes from a multicentre study of HDR monotherapy with a single fraction of 19 Gy for localized prostate cancer" [Radiother. Oncol. 216 (2026) 111385].

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

A sinGle-arm phase II study to assess efficacy, tOxicity, and quAlity of life following 27Gy in 6 fractions palliative intensity modulated radiotherapy with early integration of palliative care (GOAL27-6).

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Detection of errors in organs at risk delineations for radiotherapy for clinical trial reviews.

Physics in medicine and biology·2026
Same author

PACE-NODES: A phase III randomised trial of 5 fraction prostate stereotactic body radiotherapy (SBRT) versus 5 fraction prostate and pelvic nodal SBRT.

Clinical and translational radiation oncology·2026

Related Experiment Video

Updated: Feb 8, 2026

A Model to Simulate Clinically Relevant Hypoxia in Humans
09:54

A Model to Simulate Clinically Relevant Hypoxia in Humans

Published on: December 22, 2016

9.4K

Clinical trials targeting hypoxia.

Hannah Tharmalingham1,2,3, Peter Hoskin1,2,3,4

  • 1Mount Vernon Cancer Centre, Northwood, UK.

The British Journal of Radiology
|July 7, 2018
PubMed
Summary

Tumour hypoxia, or low oxygen, significantly impacts radiation resistance. Strategies to overcome this, like nimorazole and carbogen, show promise in improving cancer control and survival rates.

More Related Videos

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K
Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
03:26

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain

Published on: March 8, 2024

3.6K

Related Experiment Videos

Last Updated: Feb 8, 2026

A Model to Simulate Clinically Relevant Hypoxia in Humans
09:54

A Model to Simulate Clinically Relevant Hypoxia in Humans

Published on: December 22, 2016

9.4K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K
Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
03:26

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain

Published on: March 8, 2024

3.6K

Area of Science:

  • Oncology
  • Radiation Oncology
  • Cancer Biology

Background:

  • Tumour hypoxia has been recognized as a key factor in radiation resistance for over a century.
  • Tumour oxygen levels are influenced by complex diffusion and perfusion dynamics.
  • Clinical strategies to counteract tumour hypoxia aim to enhance radiation therapy efficacy.

Purpose of the Study:

  • To review the historical and current strategies for modifying tumour hypoxia to improve radiation therapy outcomes.
  • To highlight the successes and failures of clinical trials investigating hypoxia modification.
  • To discuss the role of biomarkers in selecting patients for future hypoxia-targeted therapies.

Main Methods:

  • Review of clinical trials and meta-analyses on tumour hypoxia modification strategies.
  • Examination of various agents including hyperbaric oxygen, oxygen mimetics (e.g., nimorazole), carbogen, nicotinamide, and mitochondrial complex inhibitors.
  • Assessment of biomarkers for identifying hypoxic tumours and predicting treatment response.

Main Results:

  • Meta-analyses confirm that hypoxia modification significantly impacts tumour control and patient survival.
  • Nimorazole demonstrated significant locoregional control in advanced laryngeal cancer.
  • Carbogen and nicotinamide showed survival benefits in muscle-invasive bladder cancer and locoregional control in hypopharyngeal cancer.
  • Mitochondrial complex inhibitors are emerging as potential radiosensitizers, with atovaquone in clinical trials.

Conclusions:

  • Despite past challenges, hypoxia modification remains a crucial strategy in radiation oncology.
  • The development of biomarkers (e.g., CAIX, Glut1, gene signatures) is essential for patient stratification in future trials.
  • Personalized approaches targeting tumour oxygenation hold significant potential for improving cancer treatment outcomes.